Gene · 3913
NIH grants2,633
NIH grants whose papers are about the gene, through NIH's grant-paper links.
681 to 700 of 2,633
Download this page as JSON| Grant | Title | LAMB2 papers | Newest fiscal year |
|---|---|---|---|
| R01HL149748 | Molecular basis for defective pericyte-endothelial cell interactions regulating vascular malformations | 1 | 2023 |
| R01HL150586 | Human iPSC-derived atrial cardiomyocytes to model atrial fibrillation in a dish | 1 | 2023 |
| R01MH081880 | Genetic Control of Basal Telencephalic Development | 1 | 2023 |
| R01MH116037 | Discoveries in ADHD genomics: Help or hype in clinical settings? | 1 | 2023 |
| R01MH118278 | Predicting the multi-omic impact of psychiatric GWAS associations | 1 | 2023 |
| R01NS031744 | Structure and Function of the Acetylcholine Receptor | 1 | 2023 |
| R01NS044025 | Neonatal Stroke: The Role of Microglia-derived Extracellular Vesicles | 1 | 2023 |
| R01NS083897 | Essential requirements of Eif4a3 in brain development and disease | 1 | 2023 |
| R01NS106008 | Functional 3D tissue-engineering models of the cerebrovasculature incorporating stem cell-derived brain microvascular endothelial cells, pericytes, and astrocytes | 1 | 2023 |
| R01NS106612 | NAD+ Pathway Signaling in Glioblastoma Tumor Growth and Therapy Resistance | 1 | 2023 |
| R01NS111715 | The Peripheral Nervous System: A Window into Krabbe Disease | 1 | 2023 |
| R03CA270679 | Recording the natural history of cancer progression using a Crainbow model of HER2+ cancer | 1 | 2023 |
| R21CA252162 | A Bioengineered Model of Tumor Vessel Interactions in Pancreatic Cancer | 1 | 2023 |
| R21DE031366 | An inducible molecular memory system to unravel the mechanisms of drug resistance in head and neck cancer | 1 | 2023 |
| R21HD114044 | Biofabricating Seminiferous Tubules for In Vitro Spermatogenesis | 1 | 2023 |
| R25GM109439 | University of Chicago Initiative for Maximizing Student Development (IMSD) - Renewal 01 | 1 | 2023 |
| R33DA047527 | Investigating the Systems Genetics of the Patterns of Polysubstance Abuse and Addiction | 1 | 2023 |
| R33HL163711 | An Enabling Technology for Human Cardiomyocyte Manufacturing | 1 | 2023 |
| R35GM131709 | Structure and Function of Paxillin | 1 | 2023 |
| R37AI037526 | Class Switch Recombination in B Lymphocytes | 1 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3913/grants?page=35